| PRD_000357 | Name: | 3-methyl-L-valyl-L-prolyl-L-isoleucine | Formula: | C17 H31 N3 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000358 | Name: | (1R)-1-benzyl-1-methyl-1-(2-{[4-(1-methylethyl)phenyl]amino}-2-oxoethyl)-2-{(2S)-4-methyl-2-[(trifluoroacetyl)amino]pentanoyl}diazanium | Formula: | C27 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000360 | Name: | N-(trifluoroacetyl)-L-valyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C17 H19 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000361 | Name: | N~2~-[(2R)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]-N-{(1R)-1-(cyclohexylmethyl)-3,3-difluoro-2,2-dihydroxy-4-[(2-morpholin-4-ylethyl)amino]-4-oxobutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C36 H56 F2 N7 O8 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000362 | Name: | INHIBITOR VAL-SER-GLN-ASN-LEU-PSI(CH(OH)-CH2)-VAL-ILE-VAL (U-85548E) | Formula: | C40 H73 N9 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000363 | Name: | Ace-LEALFQ-ethylpropionate | Formula: | C40 H63 N7 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000364 | Name: | N-(trifluoroacetyl)-L-phenylalanyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C21 H19 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000365 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-prolinamide | Formula: | C22 H32 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000366 | Name: | N-(trifluoroacetyl)-L-leucyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C18 H21 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000367 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-phenylalaninamide | Formula: | C26 H34 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000368 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-leucinamide | Formula: | C23 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000369 | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H36 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000370 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-hydroxy-L-alaninamide | Formula: | C17 H25 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000371 | Name: | N-benzyl-N~2~-[(2R)-2-(hydroxycarbamoyl)-4-methylpentanoyl]-L-alpha-asparagine | Formula: | C18 H25 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000372 | Name: | (3R)-2-[N-(furan-2-ylcarbonyl)-L-leucyl]-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid | Formula: | C23 H25 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000374 | Name: | 3-[(2S)-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxo-3-piperidin-1-ylpropyl]benzenecarboximidamide | Formula: | C22 H28 N4 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000376 | Name: | amino{[(4S)-4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)-5-(4-ethylpiperidin-1-yl)-5-oxopentyl]amino}methaniminium | Formula: | C25 H39 N6 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000378 | Name: | N-(ethoxycarbonyl)-L-leucyl-N-[(1R,2S,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-leucinamide | Formula: | C29 H55 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000379 | Name: | N-acetylated chloromethylated fibrinopeptide A | Formula: | C47 H75 Cl N13 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000380 | Name: | N-[(1R)-1-carboxy-3-phenylpropyl]-L-leucyl-L-tryptophan | Formula: | C27 H33 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000381 | Name: | SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE | Formula: | C25 H35 Cl N4 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000382 | Name: | N-[(1R,2R,4R)-1-(cyclohexylmethyl)-2-hydroxy-6-methyl-4-{[(2R)-2-methylbutyl]carbamoyl}heptyl]-3-(1H-imidazol-3-ium-4-y
l)-N~2~-[3-naphthalen-1-yl-2-(naphthalen-1-ylmethyl)propanoyl]-L-alaninamide | Formula: | C51 H68 N5 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000383 | Name: | N-{(3S)-3-[(tert-butoxycarbonyl)amino]-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | Formula: | C38 H49 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000384 | Name: | N-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-glutaminyl-L-phenylalaninamide | Formula: | C38 H50 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000385 | Name: | N-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | Formula: | C38 H49 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|